See also this year's filing and all EDGAR filings for this company.
PDF Report 0001694665_2023_Evelo_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001694665, Evelo Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 51,573,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,842,000 |
| 3 | remainder_Assets | 8,026,000 |
| 4 | LiabilitiesCurrent | 12,395,000 |
| 5 | LiabilitiesNoncurrent | 57,038,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,912,000 |
| 9 | ResearchAndDevelopmentExpense | 78,554,000 |
| 10 | remainder_Expenses | 930,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -5,131,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 64,441,000 |
| 1 | Liabilities | 69,433,000 |
| 2 | Expenses | 109,396,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -4,992,000 |
| 5 | NetIncome | -114,527,000 |
| 6 | ComprehensiveNetIncome | -114,527,000 |
| 7 | BaseVar | 124,200,500 |
| 8 | EconomicCapitalRatio | -1.84 |